US Market News
2月前
Ridgetech, Inc. Announces 1-for-150 Reverse Share SplitApril 3, 2026 12:00 PM
PR Newswire (US)
HANGZHOU, China, April 3, 2026 /PRNewswire/ -- Ridgetech, Inc., a Cayman Islands exempted company (the "Company") (Nasdaq: RDGT), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced that it expects to implement a 1-for-150 reverse share split on its ordinary shares ("Ordinary Shares") effective Tuesday, April 7, 2026 at 5:00 p.m. Eastern Time, with trading to begin on a split-adjusted basis at the market open on the next trading day. Trading in the Ordinary Shares will continue on the Nasdaq Capital Market under the symbol "RDGT." The new CUSIP number for the Ordinary Shares following the reverse share split is G2124G 203. As of April 2, 2026, the Company had 134,835,960 Ordinary Shares outstanding; following the reverse share split, the Company expects to have approximately 898,906 Ordinary Shares outstanding, subject to adjustment for fractional share rounding.Upon the effectiveness of the reverse share split, every 150 shares of the Company's issued and outstanding Ordinary Shares, par value US$0.001 per share, will automatically be converted into one issued and outstanding Ordinary Share, par value US$0.15 per share. No fractional shares will be issued as a result of the reverse share split. Instead, any fractional shares that would have resulted from the split will be rounded up to the nearest whole share. The reverse share split affects all shareholders uniformly and will not alter any shareholder's percentage interest in the Company's outstanding Ordinary Shares, except for adjustments that may result from the treatment of fractional shares.The reverse share split at a ratio of 1-for-150 shares was approved by the Company's board of directors and its shareholders. The Company is to file a Fifth Amended and Restated Memorandum and Articles of Association with the Cayman Islands Registrar of Companies effective April 7, 2026.About Ridgetech, Inc.Ridgetech, Inc. ("Ridgetech" or the "Company"), is a growing online and offline wholesale distributor of pharmaceutical and other healthcare products in China. Ridgetech actively trades on popular online distribution platforms nationwide and has its own online distribution platform. The Company believes that trading on these platforms offers greater opportunities to distribute pharmaceutical products nationwide. For more information about the Company, please visit www.ridgetch.com. The Company routinely posts important information on its website.Forward-Looking StatementsCertain statements in this press release are forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. These forward-looking statements include, but are not limited to, statements concerning the expected benefits from the cooperation arrangements with premier pharmaceutical companies and the investment in its proprietary digital customer operations platform. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to," or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct. Factors that could cause actual results or events to differ materially from those reflected in the Company's forward-looking statements including risks related to the Company's ability to satisfy applicable procurement conditions, changes in market demand, the Company's ability to successfully implement and promote its digital platform, and those other risks described in the Company's most recent registration statement, most recent annual report on Form 20-F and in its other filings with the U.S. Securities and Exchange Commission.For more information, please contact:Company Contact: Frank Zhao
Interim Chief Executive Officer and Chief Financial Officer
+86-571-88077108
frank.zhao@ridgetch.comInvestor Relations Contact:Tina Xiao
Ascent Investor Relations LLC
+1-646-932-7242
investors@ascent-ir.com
View original content:https://www.prnewswire.com/news-releases/ridgetech-inc-announces-1-for-150-reverse-share-split-302733570.htmlSOURCE Ridgetech, Inc.
Original: Ridgetech, Inc. Announces 1-for-150 Reverse Share Split
S-BEES-BUMBLEBEE
3年前
China Jo-Jo Drugstores Announces the Termination of the Previously Proposed Registered Direct Offering
PR Newswire
April 19, 2023·
HANGZHOU, China, April 19, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, announced today that the previously announced registered direct offering to issue 2,258,888 ordinary shares and registered warrants to purchase up to 4,517,776 ordinary shares to an institutional investor was terminated. No securities were sold pursuant to the Company's shelf registration statement on Form F-3 (No. 333-259692) in connection with such previously proposed offering.
About China Jo-Jo Drugstores, Inc.
China Jo-Jo Drugstores, Inc. ("Jo-Jo Drugstores" or the "Company"), is a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a provider of healthcare services in China. Jo-Jo Drugstores currently operates an online pharmacy and retail drugstores with licensed doctors on site for consultation, examination and treatment of common ailments at scheduled hours. It is also a wholesale distributor of products similar to those carried in its pharmacies. For more information about the Company, please visit http://jiuzhou360.com. The Company routinely posts important information on its website.
Forward-Looking Statements
This press release contains information about the Company's view of its future expectations, plans and prospects that constitute forward-looking statements. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets into its portfolio of products and services, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the technical skills and experience necessary to meet the requirements of its clients, and its ability to protect its intellectual property. The Company's encourages you to review other factors that may affect its future results in the Company's annual reports and in its other filings with the Securities and Exchange Commission.
For more information, please contact:
Company Contact:
Frank Zhao
Chief Financial Officer
+86-571-88077108
frank.zhao@jojodrugstores.com
Investor Relations Contact:
Tina Xiao
Ascent Investor Relations LLC
+1-917-609-0333
tina.xiao@ascent-ir.com
View original content:https://www.prnewswire.com/news-releases/china-jo-jo-drugstores-announces-the-termination-of-the-previously-proposed-registered-direct-offering-301801291.html
SOURCE China Jo-Jo Drugstores, Inc.
Link: https://finance.yahoo.com/news/china-jo-jo-drugstores-announces-123000033.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAIOq_bombIalPU7m8Vtj_rK_qws1ve5wbekFH9nO91hILmmhmk0852NUQgrUmQx8ANzAg6j9NT-CJpTeL1rlnksWyaBj_jKWFOLp0tTyI8yOwOwcoPZYNsGKXddFZAoeorEpdgBCJrU2-3eEGl7r-TR7i1kZbCrMYxUKxiuOAQfh
$$$CJJD$$$
S-BEES-BUMBLEBEE
3年前
China Jo-Jo Drugstores Receives Hangzhou Municipal People's Government Quality Management Excellence Award
PR Newswire
May 2, 2023
HANGZHOU, China, May 2, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that the Company had received the Hangzhou Municipal People's Government Quality Management Excellence Award (the "Award"), the most prestigious quality recognition established by Hangzhou Municipal People's Government and reviewed by the Market Supervision and Administration Bureau of Hangzhou City.
Established in 2010, the Award is designed to recognize enterprises or organizations that have implemented exceptional performance management and created notable economic and social benefits in areas such as production, construction, services, and environmental protection. The Company is one of the only five companies selected for the Award, reflecting recognition of the Company's accomplishments in promoting quality management innovation and achieving performance excellence.
After 20 years of effort, the Company has evolved into a comprehensive healthcare service enterprise providing wholesale, retail, and e-commerce of pharmaceuticals, medical treatment services, traditional Chinese medicine planting, health management, and medical technology. Jo-Jo Drugstores keeps innovating its business model and has become one of the first commercial insurance designated pharmacies in China, the first online e-commerce drugstore in Zhejiang Province (one of the wealthiest provinces in China with over $1 trillion nominal GDP), the first private medical institution with Internet hospital qualifications licensed by the Zhejiang Provincial Health Commission, one of the first future community pilot units in Zhejiang Province, one of the first five-star people's livelihood pharmaceutical service stations in Zhejiang Province, and one of the first new retail enterprises in Hangzhou (the capital and largest city of Zhejiang Province). The Company has been ranked among the Top 100 chain drugstores in China in terms of value and comprehensive strength for three consecutive years, with rapid growth in overall business, store expansion, new retail business, and B2C sales.
Mr. Lei Liu, Chairman and CEO of Jo-Jo Drugstores, commented, "We are deeply honored to be selected for the Award, which is a testament and encouragement to the Company. We view this as the opening of a new charter for the Company's future growth. Moving forward, Jo-Jo Drugstores will continue to optimize the excellent performance management system, actively foster the high-quality development of the Company, and serve as an exemplary enterprise within the industry. We will align ourselves with the development plan as outlined in the project of 'Healthy China 2030', and strive to make further contributions to building a robust city of quality in Hangzhou while supporting local economic and social progress."
About China Jo-Jo Drugstores, Inc.
China Jo-Jo Drugstores, Inc. ("Jo-Jo Drugstores" or the "Company"), is a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a provider of healthcare services in China. Jo-Jo Drugstores currently operates an online pharmacy and retail drugstores with licensed doctors on site for consultation, examination and treatment of common ailments at scheduled hours. It is also a wholesale distributor of products similar to those carried in its pharmacies. For more information about the Company, please visit http://jiuzhou360.com. The Company routinely posts important information on its website.
For more information, please contact:
Company Contact:
Frank Zhao
Chief Financial Officer
+86-571-88077108
frank.zhao@jojodrugstores.com
Investor Relations Contact:
Tina Xiao
Ascent Investor Relations LLC
+1-917-609-0333
tina.xiao@ascent-ir.com
View original content:https://www.prnewswire.com/news-releases/china-jo-jo-drugstores-receives-hangzhou-municipal-peoples-government-quality-management-excellence-award-301812315.html
SOURCE China Jo-Jo Drugstores, Inc.
Link: https://finance.yahoo.com/news/china-jo-jo-drugstores-receives-123000793.html?.tsrc=rss
$$$CJJD$$$